We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Idexx Laboratories
IDXX
$44B
| $111K | ﹤0.01% |
200
| – | – |
2022 Q1
7 quarters
|
|
552
Littelfuse
LFUS
$9.7B
| $111K | ﹤0.01% |
410
| – | – |
2022 Q1
7 quarters
|
|
553
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.77B
| $111K | ﹤0.01% |
1,501
+3
| +0.2% | +$198 |
2022 Q1
7 quarters
|
|
554
Medical Properties Trust
MPT
$1.64B
| $111K | ﹤0.01% |
21,100
+8,500
| +67% | +$41.6K |
2022 Q1
7 quarters
|
|
555
Realty Income
O
$53.3B
| $111K | ﹤0.01% |
1,891
+239
| +14% | +$12.5K |
2022 Q1
7 quarters
|
|
|
KCLI
556
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
| $111K | ﹤0.01% |
3,000
| – | – |
2022 Q1
7 quarters
|
|
557
Bank of America Depository Shares Series KK
BAC.PRM
$1.02B
| $110K | ﹤0.01% |
4,745
+632
| +15% | +$13.9K |
2022 Q2
6 quarters
|
|
558
MDU Resources
MDU
$4.02B
| $110K | ﹤0.01% |
9,928
| – | – |
2022 Q1
7 quarters
|
|
559
Nuveen ESG International Developed Markets Equity ETF
NUDM
$878M
| $110K | ﹤0.01% |
3,735
| – | – |
2022 Q4
4 quarters
|
|
560
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.6B
| $108K | ﹤0.01% |
1,162
| – | – |
2013 Q2
42 quarters
|
|
561
First Financial Bancorp
FFBC
$3.35B
| $108K | ﹤0.01% |
4,446
| – | – |
2022 Q1
7 quarters
|
|
562
Quanta Services
PWR
$89.6B
| $108K | ﹤0.01% |
500
| – | – |
2022 Q1
7 quarters
|
|
563
AstraZeneca
AZN
$262B
| $106K | ﹤0.01% |
790
+394
| +99% | +$51.2K |
2022 Q1
7 quarters
|
|
564
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.1B
| $106K | ﹤0.01% |
481
| – | – |
2022 Q1
7 quarters
|
|
565
Addus HomeCare
ADUS
$2.2B
| $104K | ﹤0.01% |
1,100
| – | – |
2022 Q1
7 quarters
|
|
566
International Paper
IP
$17.8B
| $104K | ﹤0.01% |
2,867
| – | – |
2022 Q1
7 quarters
|
|
567
Fomento Económico Mexicano
FMX
$44B
| $103K | ﹤0.01% |
785
| – | – |
2022 Q1
7 quarters
|
|
568
ServiceNow
NOW
$155B
| $103K | ﹤0.01% |
730
+150
| +26% | +$18.9K |
2023 Q3
1 quarter
|
|
569
Cohen & Steers
CNS
$3.7B
| $102K | ﹤0.01% |
1,319
| – | – |
2022 Q1
7 quarters
|
|
570
BlackRock Core Bond Trust
BHK
$607M
| $100K | ﹤0.01% |
9,102
-2,322
| -20% | -$23.2K |
2014 Q1
39 quarters
|
|
571
Gartner
IT
$13.9B
| $100K | ﹤0.01% |
223
| – | – |
2022 Q1
7 quarters
|
|
572
America Movil
AMX
$68.4B
| $99K | ﹤0.01% |
5,400
| – | – |
2022 Q1
7 quarters
|
|
573
U.S. Small Cap Portfolio ETF Class Shares
DFAS
$15.1B
| $99K | ﹤0.01% |
1,645
| – | – |
2022 Q1
7 quarters
|
|
574
AGCO
AGCO
$7.33B
| $98K | ﹤0.01% |
800
| – | – |
2022 Q1
7 quarters
|
|
575
Global Payments
GPN
$22.4B
| $98K | ﹤0.01% |
764
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.